HOPMAN MARK (Chief Commercial Officer) sold 0.7% of their position (370.00 shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $7.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/5/2026ACC: 0002048497-26-000018
Officer· Chief Commercial Officer
Since Mar 2026
-370.00
Net shares
Net seller
$7.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
370.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−370.00
Price / share
$18.96
Trade value
$7.02K
% of position
0.7%
10/1/2026
56.48K→56.11K
Total
Net shares
−370.00
Net value
-$7.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2026 | S · Sale | −370.00 | $18.96 | $7.02K | 0.7% | 56.48K | 56.11K |
| Total | −370.00 | -$7.02K | ||||||
Derivative Transactions0
No derivative transactions reported